首页 > 最新文献

Rofo-fortschritte Auf Dem Gebiet Der Rontgenstrahlen Und Der Bildgebenden Verfahren最新文献

英文 中文
Strahlenschutzkurse. 辐射防护课程。
IF 1.3 4区 医学 Q3 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2024-10-01 Epub Date: 2024-09-18 DOI: 10.1055/a-2374-4005
{"title":"Strahlenschutzkurse.","authors":"","doi":"10.1055/a-2374-4005","DOIUrl":"10.1055/a-2374-4005","url":null,"abstract":"","PeriodicalId":21490,"journal":{"name":"Rofo-fortschritte Auf Dem Gebiet Der Rontgenstrahlen Und Der Bildgebenden Verfahren","volume":null,"pages":null},"PeriodicalIF":1.3,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142294404","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Technical and clinical success analysis of transarterial embolization therapy in type II endoleaks following endovascular aortic repair. 经动脉栓塞疗法治疗血管内主动脉修复术后 II 型内漏的技术和临床成功率分析。
IF 1.3 4区 医学 Q3 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2024-10-01 DOI: 10.1055/a-2384-4601
Kristina Krompaß, Jan-Peter Grunz, Anne Marie Augustin, Dominik Peter, Frank Schönleben, Thorsten Bley, Ralph Kickuth

This single-center study investigated the safety and efficacy of transarterial embolization of type II endoleaks for expanding aneurysm sacs following endovascular aortic repair (EVAR).36 patients (33 men, 75.9±6.6 years) underwent a total of 50 endovascular procedures for type II endoleak embolization between 2008 and 2023. Analyses included the assessment of patient risk profiles, aneurysm morphology, and endoleak characteristics. Outcome parameters comprised the technical success (i.e., complete lack of blood flow in the previously perfused aneurysm sac) and complication rates, while clinical success was defined as the absence of endoleak persistence or recurrence and freedom from aneurysm enlargement > 0.5 cm over the follow-up period.Transarterial embolization was technically successful in 84% of procedures with a complication rate of 2%. Most interventions were coil-based (72%), while a small number relied solely on liquid embolic agents (14%). Absence of a persisting endoleak in the earliest follow-up could be demonstrated in 75.6% of cases, whereas the absence rate for endoleak recurrence was substantially lower (46.3%). No aneurysm enlargement > 0.5 cm during follow-up was ascertained after 73.2% of interventions.Transarterial embolization represents a safe treatment for type II endoleaks after EVAR. While embolization was moderately effective in preventing further expansion of aneurysms due to endoleak recurrence, most procedures were successful in permanently eliminating the targeted feeder vessels. · Transarterial embolization of type II endoleaks has a high technical success rate.. · The emergence of new feeder vessels may necessitate multiple procedures over time.. · Patient risk profiles did not factor into the clinical outcome.. · Krompaß K, Grunz JP, Augustin AM et al. Technical and clinical success analysis of transarterial embolization therapy in type II endoleaks following endovascular aortic repair. Fortschr Röntgenstr 2024; DOI 10.1055/a-2384-4601.

这项单中心研究调查了经动脉栓塞II型内漏对血管内主动脉修复术(EVAR)后动脉瘤囊扩张的安全性和有效性。2008年至2023年期间,36名患者(33名男性,75.9±6.6岁)共接受了50次血管内II型内漏栓塞手术。分析包括对患者风险概况、动脉瘤形态和内漏特征的评估。结果参数包括技术成功率(即先前灌注的动脉瘤囊完全无血流)和并发症发生率,而临床成功率则定义为随访期间无内漏持续或复发,动脉瘤无增大> 0.5 厘米。大多数介入治疗采用线圈栓塞(72%),少数仅使用液体栓塞剂(14%)。在最早的随访中,75.6%的病例可以证明没有持续性内漏,而内漏复发的无内漏率则低很多(46.3%)。经动脉栓塞是治疗 EVAR 后 II 型内漏的一种安全方法。经动脉栓塞术是EVAR术后治疗II型内漏的安全方法。虽然栓塞术在防止内漏复发导致动脉瘤进一步扩大方面效果一般,但大多数手术都成功地永久性消除了目标馈血管。- 经动脉栓塞治疗 II 型内漏的技术成功率很高。- 随着时间的推移,新的馈源血管的出现可能需要多次手术。- 患者的风险状况并不影响临床结果- Krompaß K、Grunz JP、Augustin AM 等人.血管内主动脉修复术后 II 型内膜漏经动脉栓塞疗法的技术和临床成功率分析.Fortschr Röntgen.Fortschr Röntgenstr 2024; DOI 10.1055/a-2384-4601.
{"title":"Technical and clinical success analysis of transarterial embolization therapy in type II endoleaks following endovascular aortic repair.","authors":"Kristina Krompaß, Jan-Peter Grunz, Anne Marie Augustin, Dominik Peter, Frank Schönleben, Thorsten Bley, Ralph Kickuth","doi":"10.1055/a-2384-4601","DOIUrl":"https://doi.org/10.1055/a-2384-4601","url":null,"abstract":"<p><p>This single-center study investigated the safety and efficacy of transarterial embolization of type II endoleaks for expanding aneurysm sacs following endovascular aortic repair (EVAR).36 patients (33 men, 75.9±6.6 years) underwent a total of 50 endovascular procedures for type II endoleak embolization between 2008 and 2023. Analyses included the assessment of patient risk profiles, aneurysm morphology, and endoleak characteristics. Outcome parameters comprised the technical success (i.e., complete lack of blood flow in the previously perfused aneurysm sac) and complication rates, while clinical success was defined as the absence of endoleak persistence or recurrence and freedom from aneurysm enlargement > 0.5 cm over the follow-up period.Transarterial embolization was technically successful in 84% of procedures with a complication rate of 2%. Most interventions were coil-based (72%), while a small number relied solely on liquid embolic agents (14%). Absence of a persisting endoleak in the earliest follow-up could be demonstrated in 75.6% of cases, whereas the absence rate for endoleak recurrence was substantially lower (46.3%). No aneurysm enlargement > 0.5 cm during follow-up was ascertained after 73.2% of interventions.Transarterial embolization represents a safe treatment for type II endoleaks after EVAR. While embolization was moderately effective in preventing further expansion of aneurysms due to endoleak recurrence, most procedures were successful in permanently eliminating the targeted feeder vessels. · Transarterial embolization of type II endoleaks has a high technical success rate.. · The emergence of new feeder vessels may necessitate multiple procedures over time.. · Patient risk profiles did not factor into the clinical outcome.. · Krompaß K, Grunz JP, Augustin AM et al. Technical and clinical success analysis of transarterial embolization therapy in type II endoleaks following endovascular aortic repair. Fortschr Röntgenstr 2024; DOI 10.1055/a-2384-4601.</p>","PeriodicalId":21490,"journal":{"name":"Rofo-fortschritte Auf Dem Gebiet Der Rontgenstrahlen Und Der Bildgebenden Verfahren","volume":null,"pages":null},"PeriodicalIF":1.3,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142366398","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[The many different faces of MOGAD in the MRI: From FUEL to FLAMES]. [MRI 中 MOGAD 的多种不同面孔:从燃料到火焰]。
IF 1.3 4区 医学 Q3 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2024-10-01 Epub Date: 2024-02-26 DOI: 10.1055/a-2238-6462
Marius Horger, Georg Gohla, Eva-Maria Konrad, David Baur, Markus Kowarik, Nick Farhang, Christer Ruff, Stefan Heckl
{"title":"[The many different faces of MOGAD in the MRI: From FUEL to FLAMES].","authors":"Marius Horger, Georg Gohla, Eva-Maria Konrad, David Baur, Markus Kowarik, Nick Farhang, Christer Ruff, Stefan Heckl","doi":"10.1055/a-2238-6462","DOIUrl":"10.1055/a-2238-6462","url":null,"abstract":"","PeriodicalId":21490,"journal":{"name":"Rofo-fortschritte Auf Dem Gebiet Der Rontgenstrahlen Und Der Bildgebenden Verfahren","volume":null,"pages":null},"PeriodicalIF":1.3,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139973328","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Safety, Efficacy and Outcome of Rotational Thrombectomy assisted Endovascular Revascularisation of the Superior Mesenteric Artery in Acute Thromboembolic Mesenteric Ischaemia. 急性血栓栓塞性肠系膜缺血中旋转血栓切除术辅助肠系膜上动脉血管内再通术的安全性、疗效和结果
IF 1.3 4区 医学 Q3 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2024-10-01 Epub Date: 2024-03-13 DOI: 10.1055/a-2234-0333
Annette Thurner, Dominik Peter, Giulia Dalla Torre, Sven Flemming, Ralph Kickuth

Purpose:  To evaluate the efficacy and safety of percutaneous rotational thrombectomy-assisted endovascular revascularization of acute thromboembolic superior mesenteric artery occlusions in acute mesenteric ischemia.

Materials and methods:  Fifteen cases of percutaneous rotational thrombectomy- assisted (Rotarex S, BD, USA) revascularization were retrospectively analyzed. The etiology was embolic in 40 % of cases and thrombotic in 60 %. A "Thrombectomy in Visceral Ischemia" (TIVI) 5-point score determined vessel patency at presentation, after percutaneous rotational thrombectomy, and after adjunctive technologies. TIVI 3 indicated nearly complete revascularization (minimal residual side branch thrombus). TIVI 4 indicated complete revascularization. Technical success was defined as successful device application and a final TIVI score of 3/4 after adjunctive technologies. Safety and outcome were also analyzed.

Results:  Device application via femoral access was feasible in 100 % of cases and improved flow in 86.7 % of cases (1 × TIVI 0→1, 11 × TIVI 0→2, 1 × TIVI 1→2). There was no change in 13.3 % of cases (2 × TIVI 2→2). Additional devices resulted in further flow improvement in 93.3 % of cases (8 × TIVI 3, 6 × TIVI 4). One recanalization failed (TIVI 2→2→2). After adjunctive technologies (10 × manual aspiration, 11 × angioplasty, 9 × stenting), the technical success rate was 93.3 %. The mean procedure time was 40.5(± 14) minutes for embolism and 72.1(± 20) minutes for thrombosis. There was one device-related major complication (catheter tip fracture) resulting in a device-related safety rate of 93.3 %. The overall major complication rate was 20 %. Surgical exploration (13 ×), bowel resection (9 ×) and Fogarty embolectomy/bypass (3 ×) were also performed. The 30-day mortality rate was 40 %.

Conclusion:  Percutaneous rotational thrombectomy is an effective adjunct for rapid endovascular recanalization of acute thromboembolic superior mesenteric artery occlusions with an acceptable rate of major procedural complications.

Key points:   · Percutaneous rotational thrombectomy-assisted superior mesenteric artery revascularization in acute occlusive mesenteric ischemia is feasible and effective.. · Percutaneous rotational thrombectomy facilitates rapid flow restoration in native and stented superior mesenteric artery segments.. · Brachial access should be considered in the case of steep take-off angles of the superior mesenteric artery..

目的:评估急性肠系膜缺血时经皮旋转血栓切除术辅助血管内再通术治疗急性血栓栓塞性肠系膜上动脉闭塞的有效性和安全性:回顾性分析了15例经皮旋转血栓切除术辅助血管重建术(Rotarex S,美国BD公司)。病因40%为栓塞,60%为血栓。内脏缺血血栓切除术"(TIVI)5 级评分确定了发病时、经皮旋转血栓切除术后和辅助技术后的血管通畅情况。TIVI 3 表示血管几乎完全再通(残留侧支血栓极少)。TIVI 4 表示血管完全再通。技术成功的定义是成功应用设备,以及辅助技术后最终 TIVI 评分达到 3/4。此外,还对安全性和结果进行了分析:结果:100%的病例都能通过股动脉入路应用设备,86.7%的病例血流得到改善(1 × TIVI 0→1,11 × TIVI 0→2,1 × TIVI 1→2)。13.3%的病例(2 × TIVI 2→2)没有变化。在 93.3% 的病例(8 × TIVI 3,6 × TIVI 4)中,附加装置导致血流进一步改善。一次再通畅失败(TIVI 2→2→2)。在采用辅助技术(10 × 人工抽吸术、11 × 血管成形术、9 × 支架植入术)后,技术成功率为 93.3%。栓塞的平均手术时间为 40.5(± 14)分钟,血栓形成的平均手术时间为 72.1(± 20)分钟。发生了一起与设备相关的重大并发症(导管尖端断裂),设备相关安全率为 93.3%。总体主要并发症发生率为 20%。此外,还进行了手术探查(13 例)、肠切除术(9 例)和 Fogarty 栓子切除术/旁路术(3 例)。30天死亡率为40%:结论:经皮旋转血栓切除术是快速血管内再通急性血栓栓塞性肠系膜上动脉闭塞症的有效辅助手段,主要手术并发症发生率可接受:- 要点:经皮旋转血栓切除术辅助急性闭塞性肠系膜缺血的肠系膜上动脉再通术是可行且有效的。- 经皮旋转血栓切除术有助于快速恢复原生和支架置入的肠系膜上动脉段的血流。- 如果肠系膜上动脉的起始角较陡,应考虑从肱骨入路进行手术
{"title":"Safety, Efficacy and Outcome of Rotational Thrombectomy assisted Endovascular Revascularisation of the Superior Mesenteric Artery in Acute Thromboembolic Mesenteric Ischaemia.","authors":"Annette Thurner, Dominik Peter, Giulia Dalla Torre, Sven Flemming, Ralph Kickuth","doi":"10.1055/a-2234-0333","DOIUrl":"10.1055/a-2234-0333","url":null,"abstract":"<p><strong>Purpose: </strong> To evaluate the efficacy and safety of percutaneous rotational thrombectomy-assisted endovascular revascularization of acute thromboembolic superior mesenteric artery occlusions in acute mesenteric ischemia.</p><p><strong>Materials and methods: </strong> Fifteen cases of percutaneous rotational thrombectomy- assisted (Rotarex S, BD, USA) revascularization were retrospectively analyzed. The etiology was embolic in 40 % of cases and thrombotic in 60 %. A \"Thrombectomy in Visceral Ischemia\" (TIVI) 5-point score determined vessel patency at presentation, after percutaneous rotational thrombectomy, and after adjunctive technologies. TIVI 3 indicated nearly complete revascularization (minimal residual side branch thrombus). TIVI 4 indicated complete revascularization. Technical success was defined as successful device application and a final TIVI score of 3/4 after adjunctive technologies. Safety and outcome were also analyzed.</p><p><strong>Results: </strong> Device application via femoral access was feasible in 100 % of cases and improved flow in 86.7 % of cases (1 × TIVI 0→1, 11 × TIVI 0→2, 1 × TIVI 1→2). There was no change in 13.3 % of cases (2 × TIVI 2→2). Additional devices resulted in further flow improvement in 93.3 % of cases (8 × TIVI 3, 6 × TIVI 4). One recanalization failed (TIVI 2→2→2). After adjunctive technologies (10 × manual aspiration, 11 × angioplasty, 9 × stenting), the technical success rate was 93.3 %. The mean procedure time was 40.5(± 14) minutes for embolism and 72.1(± 20) minutes for thrombosis. There was one device-related major complication (catheter tip fracture) resulting in a device-related safety rate of 93.3 %. The overall major complication rate was 20 %. Surgical exploration (13 ×), bowel resection (9 ×) and Fogarty embolectomy/bypass (3 ×) were also performed. The 30-day mortality rate was 40 %.</p><p><strong>Conclusion: </strong> Percutaneous rotational thrombectomy is an effective adjunct for rapid endovascular recanalization of acute thromboembolic superior mesenteric artery occlusions with an acceptable rate of major procedural complications.</p><p><strong>Key points: </strong>  · Percutaneous rotational thrombectomy-assisted superior mesenteric artery revascularization in acute occlusive mesenteric ischemia is feasible and effective.. · Percutaneous rotational thrombectomy facilitates rapid flow restoration in native and stented superior mesenteric artery segments.. · Brachial access should be considered in the case of steep take-off angles of the superior mesenteric artery..</p>","PeriodicalId":21490,"journal":{"name":"Rofo-fortschritte Auf Dem Gebiet Der Rontgenstrahlen Und Der Bildgebenden Verfahren","volume":null,"pages":null},"PeriodicalIF":1.3,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140120458","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Kommentar zu: HERZ GEFÄßE – Koronare Kalziumlast in virtuellen PDCT. 评论:心脏血管 - 虚拟 PDCT 中的冠状动脉钙负荷。
IF 1.3 4区 医学 Q3 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2024-10-01 Epub Date: 2024-09-18 DOI: 10.1055/a-2366-4857
Christopher L Schlett
{"title":"Kommentar zu: HERZ GEFÄßE – Koronare Kalziumlast in virtuellen PDCT.","authors":"Christopher L Schlett","doi":"10.1055/a-2366-4857","DOIUrl":"10.1055/a-2366-4857","url":null,"abstract":"","PeriodicalId":21490,"journal":{"name":"Rofo-fortschritte Auf Dem Gebiet Der Rontgenstrahlen Und Der Bildgebenden Verfahren","volume":null,"pages":null},"PeriodicalIF":1.3,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142294398","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Value of contrast-enhanced sonography in the diagnosis of vesicoureteral reflux. 造影剂增强超声诊断膀胱输尿管反流的价值。
IF 1.3 4区 医学 Q3 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2024-10-01 Epub Date: 2024-02-26 DOI: 10.1055/a-2254-5490
Patrick Conen, Janine Thiemann, Regina Stredele, Dirk Andre Clevert

Background:  Contrast-enhanced ultrasound of the urinary tract and bladder (ceVUS) is an alternative examination method to micturition cysturethrography (MCU/VCUG) for suspected vesicoureteral reflux (VUR) that is increasing in practice. The purpose of this review is to present the current value of ceVUS in the diagnosis.

Method:  A systematic literature search was performed using the keywords "vesicoureteral reflux", "ceVUS", "VCUG" of the databases MEDLINE and Cochrane Library as well as a review of current German, European, and American guidelines on this topic. In addition, recommendations for action in clinical practice were developed.

Conclusion:  ceVUS is a quick-to-learn examination method that is equivalent to VCUG for the diagnosis of vesicoureteral reflux and should be used as the diagnostic method of first choice when available given the absence of radiation exposure.

Key points:   · Like VCUG, ceVUS is the diagnostic method of first choice in suspected vesicoureteral reflux and should be used preferentially given the absence of radiation exposure.. · Especially in comparison to the alternative VCUG, ceVUS is a quick-to-learn examination method.. · ceVUS can also be used to diagnose other pathologies of the lower urinary tract..

Citation format: · Conen P, Thiemann J, Stredele R et al. Value of contrast-enhanced sonography in the diagnosis of vesicoureteral reflux. Fortschr Röntgenstr 2024; 196: 1022 - 1028.

背景:尿路和膀胱对比增强超声检查(ceVUS)是一种可替代排尿膀胱造影术(MCU/VCUG)的检查方法,可用于疑似膀胱输尿管反流(VUR)的检查,在实践中应用越来越广泛。本综述旨在介绍 ceVUS 目前在诊断中的价值:方法:在 MEDLINE 和 Cochrane Library 数据库中以 "膀胱输尿管反流"、"ceVUS"、"VCUG "为关键词进行了系统性文献检索,并对德国、欧洲和美国有关该主题的现行指南进行了回顾。结论:ceVUS 是一种快速上手的检查方法,在诊断膀胱输尿管反流方面与 VCUG 相当,由于没有辐射暴露,应作为首选诊断方法:- 与VCUG一样,ceVUS也是诊断疑似膀胱输尿管反流的首选方法,在没有辐射暴露的情况下应优先使用。- 特别是与替代的 VCUG 相比,ceVUS 是一种快速上手的检查方法。- ceVUS还可用于诊断下尿路的其他病变:- Conen P, Thiemann J, Stredele R et al.对比增强超声造影在诊断膀胱输尿管反流中的价值。Fortschr Röntgenstr 2024; DOI: 10.1055/a-2254-5490.
{"title":"Value of contrast-enhanced sonography in the diagnosis of vesicoureteral reflux.","authors":"Patrick Conen, Janine Thiemann, Regina Stredele, Dirk Andre Clevert","doi":"10.1055/a-2254-5490","DOIUrl":"10.1055/a-2254-5490","url":null,"abstract":"<p><strong>Background: </strong> Contrast-enhanced ultrasound of the urinary tract and bladder (ceVUS) is an alternative examination method to micturition cysturethrography (MCU/VCUG) for suspected vesicoureteral reflux (VUR) that is increasing in practice. The purpose of this review is to present the current value of ceVUS in the diagnosis.</p><p><strong>Method: </strong> A systematic literature search was performed using the keywords \"vesicoureteral reflux\", \"ceVUS\", \"VCUG\" of the databases MEDLINE and Cochrane Library as well as a review of current German, European, and American guidelines on this topic. In addition, recommendations for action in clinical practice were developed.</p><p><strong>Conclusion: </strong> ceVUS is a quick-to-learn examination method that is equivalent to VCUG for the diagnosis of vesicoureteral reflux and should be used as the diagnostic method of first choice when available given the absence of radiation exposure.</p><p><strong>Key points: </strong>  · Like VCUG, ceVUS is the diagnostic method of first choice in suspected vesicoureteral reflux and should be used preferentially given the absence of radiation exposure.. · Especially in comparison to the alternative VCUG, ceVUS is a quick-to-learn examination method.. · ceVUS can also be used to diagnose other pathologies of the lower urinary tract..</p><p><strong>Citation format: </strong>· Conen P, Thiemann J, Stredele R et al. Value of contrast-enhanced sonography in the diagnosis of vesicoureteral reflux. Fortschr Röntgenstr 2024; 196: 1022 - 1028.</p>","PeriodicalId":21490,"journal":{"name":"Rofo-fortschritte Auf Dem Gebiet Der Rontgenstrahlen Und Der Bildgebenden Verfahren","volume":null,"pages":null},"PeriodicalIF":1.3,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139973348","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Failure of fat suppression? MRI of serous atrophy of the bone marrow: a follow-up case with the literature review. 脂肪抑制失败?骨髓浆液性萎缩的磁共振成像:一例随访病例及文献综述。
IF 1.3 4区 医学 Q3 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2024-10-01 Epub Date: 2024-07-19 DOI: 10.1055/a-2328-7464
Mitja Rupreht, Miraude Adriaensen, Lea Gril Jevšek, Nina Schweighofer
{"title":"Failure of fat suppression? MRI of serous atrophy of the bone marrow: a follow-up case with the literature review.","authors":"Mitja Rupreht, Miraude Adriaensen, Lea Gril Jevšek, Nina Schweighofer","doi":"10.1055/a-2328-7464","DOIUrl":"10.1055/a-2328-7464","url":null,"abstract":"","PeriodicalId":21490,"journal":{"name":"Rofo-fortschritte Auf Dem Gebiet Der Rontgenstrahlen Und Der Bildgebenden Verfahren","volume":null,"pages":null},"PeriodicalIF":1.3,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11410396/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141727722","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Faszination Radiologie. Faszination Radiologie.
IF 1.3 4区 医学 Q3 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2024-10-01 Epub Date: 2024-09-18 DOI: 10.1055/a-2374-3665
{"title":"Faszination Radiologie.","authors":"","doi":"10.1055/a-2374-3665","DOIUrl":"10.1055/a-2374-3665","url":null,"abstract":"","PeriodicalId":21490,"journal":{"name":"Rofo-fortschritte Auf Dem Gebiet Der Rontgenstrahlen Und Der Bildgebenden Verfahren","volume":null,"pages":null},"PeriodicalIF":1.3,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142294395","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Kommentar zu MSK – Sarkopenie: Muskelreferenzwerte von Th5 bis L3. 评论 MSK - Sarcopenia:从 Th5 到 L3 的肌肉参考值。
IF 1.3 4区 医学 Q3 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2024-10-01 Epub Date: 2024-09-18 DOI: 10.1055/a-2316-3508
Daniel Vogele
{"title":"Kommentar zu MSK – Sarkopenie: Muskelreferenzwerte von Th5 bis L3.","authors":"Daniel Vogele","doi":"10.1055/a-2316-3508","DOIUrl":"10.1055/a-2316-3508","url":null,"abstract":"","PeriodicalId":21490,"journal":{"name":"Rofo-fortschritte Auf Dem Gebiet Der Rontgenstrahlen Und Der Bildgebenden Verfahren","volume":null,"pages":null},"PeriodicalIF":1.3,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142294397","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Kommentar zu: INTERVENTION – minimalinvasive Ablation von Lebertumoren in Deutschland und Österreich. 评论:干预--德国和奥地利的肝脏肿瘤微创消融术。
IF 1.3 4区 医学 Q3 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2024-10-01 Epub Date: 2024-09-18 DOI: 10.1055/a-2366-0137
Max Seidensticker
{"title":"Kommentar zu: INTERVENTION – minimalinvasive Ablation von Lebertumoren in Deutschland und Österreich.","authors":"Max Seidensticker","doi":"10.1055/a-2366-0137","DOIUrl":"10.1055/a-2366-0137","url":null,"abstract":"","PeriodicalId":21490,"journal":{"name":"Rofo-fortschritte Auf Dem Gebiet Der Rontgenstrahlen Und Der Bildgebenden Verfahren","volume":null,"pages":null},"PeriodicalIF":1.3,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142294399","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Rofo-fortschritte Auf Dem Gebiet Der Rontgenstrahlen Und Der Bildgebenden Verfahren
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1